Citadel Advisors
HHS icon

Citadel Advisors’s Harte-Hanks HHS Stock Holding History

Citadel Advisors’s Portfolio HHS Stock Details HHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-190
Closed -$11K – 9022
2015
Q2 		$11K Buy
190
+160
+533% +$10.8K ﹤0.01% 8378
2015
Q1 		$2K Buy
+30
New +$2.32K ﹤0.01% 8408
2014
Q1 		– Sell
-60
Closed -$5K – 7908
2013
Q4 		$5K Buy
60
+50
+500% +$4.08K ﹤0.01% 6820
2013
Q3 		$1K Sell
10
-30
-75% -$2.75K ﹤0.01% 6669
2013
Q2 		$3K Buy
+40
New +$3.31K ﹤0.01% 6388

Other funds holding HHS

William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
WCM
Westerly Capital Management San Francisco, California $368M AUM 42.67% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.11B AUM 20.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Citadel Advisors's HHS Position: Q3 2024 in Review

Citadel Advisors sold out of Harte-Hanks (HHS) in Q3 2024, closing a stake of 28,948 shares — an estimated $235K sold.

Citadel Advisors first reported a position in HHS in Q2 2013 and held it in 20 quarters. The position peaked at $2.42M in Q2 2013. 25 funds tracked by Wall St. Rank hold HHS as of Q3 2024.

  • Citadel Advisors reported no remaining Harte-Hanks position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 28,948 Harte-Hanks shares in Q3 2024, an estimated $235K.
  • Citadel Advisors first reported a position in Harte-Hanks in Q2 2013 and held it in 20 quarters.
  • Citadel Advisors's Harte-Hanks position peaked at $2.42M in Q2 2013.
  • 25 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.